Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Ovarian CancerNeoadjuvant ChemotherapyPrehabilitation
Interventions
BEHAVIORAL

FIT4SURGERY

The Fit4Surgery intervention consists of the FitBit Inspire HR device, the Fit4Surgery mobile app, and weekly coaching calls. Patients are asked to wear the Fitbit through the entire 9-12 weeks in which they are receiving neoadjuvant chemotherapy both when asleep and when awake. Patients are taught how to understand the Fitbit outputs on the application, for example, understanding how to monitor their steps and heart rate. Caregivers are also be encouraged to assist patients. Patients are provided with information about the benefits of physical activity and effective behavior change strategies for incorporating physical activity into their daily lives. These include things such as short bouts of activity by walking around the room during commercial breaks or planning to be dropped off a short walk from a destination.

BEHAVIORAL

Healthy Lifestyle Control

Participants assigned to this study arm are instructed to go about their usual activities and receive education about physical activity and a healthy lifestyle for ovarian cancer patients. They are encouraged to download the free Cancer.Net mobile app and visit the cancer.net website for educational materials related to ovarian cancer and survivorship. At the end of the 9-12 week intervention, participants in the Healthy Lifestyle group receive a Fitbit for their optional, personal use after surgery.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT05092763 - Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer | Biotech Hunter | Biotech Hunter